Severe iatrogenic adverse drug reaction reports: Results of the activity of the Regional Pharmacovigilance unit of central Portugal
DOI:
https://doi.org/10.32385/rpmgf.v28i1.10915Keywords:
Drug Surveillance, Postmarketing, Adverse Drug Reaction Reporting Systems, Adverse effects, CausalityAbstract
SEVERE IATROGENIC ADVERSE DRUG REACTION REPORTS: RESULTS OF THE ACTIVITY OF THE REGIONAL PHARMACOVIGILANCE UNIT OF CENTRAL PORTUGAL Objectives: This study aims to characterize the adverse drug reactions (ADR) reported to the Regional Pharmacovigilance Unit of Central Portugal (UFC), to document the contribution of reports of ADR by health professionals to pharmacovigilance in Portugal, and to identify the new knowledge produced by the activity of the UFC. Type of study: Cross-sectional. Setting: Regional Pharmacovigilance Unit of Central Portugal. Population: Spontaneous reports from the geographic area corresponding to the Health Administration of the Central Region of Portugal. Methods: Spontaneous reports (SR) of ADR received in the UFC between January 2001 and August 2011 were included. Causality was assessed using the global introspection method. Severity was assessed according to World Health Organization (WHO) criteria. Previous description of an ADR was assessed by consulting the Summary of Product Characteristics. Suspected drugs were classified in categories according to the Portuguese Drug and Therapeutics Bulletin. Suspected drugs were classified in categories according to the Bulletin. ADR were classified according to the MedDRA dictionary. Results:The UFC received 1846 SR of ADR between 2001 and August 2011. 999 met the inclusion criteria. We identified 149 (14.9%) unknown ADR and 428 (42.8%) serious ADR. 70 (7.0%) ADR were simultaneously unknown and serious and 41 (4.1%) simultaneously unknown, serious, and certain or probable. Physicians reported 577 (57.8%) ADR, of which 340 (34.0%) were reported by family physicians. Pharmacists reported 354 (35.4%) ADR and nurses 66 (6.6%). Conclusions: Unknown ADR (149; 14.9%), unknown and serious ADR (70; 7.0%) and unknown serious certain or probable ADR (41; 4.1%) received by the UFC show that SR are of great value in increasing knowledge about the safety profiles of drugsDownloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
